A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2004
12/09/2004	US20040247648 Mechanically, thermally or chemically modified corn, tapioca or potato starches and an existing drug; improved shelf-life and storage stability
12/09/2004	US20040247645 Dissolving a biocaompatible polymer in a solvent and mixing in the drug, drying and refrigerating; ocular implants for sustained release of angiogenesis inhibitors; macular degeneration
12/09/2004	US20040247643 A miniature coated tablet or covered rod implant; smaller size and larger payloads than immediate release tablets; veterinary medicine
12/09/2004	US20040247634 Treatment of parasitic disease
12/09/2004	US20040247632 Chitosan microparticles for the topical delivery of water insoluble active agents
12/09/2004	US20040247628 Kit for the preparation of a pharmaceutical composition
12/09/2004	US20040247627 Ready-to-use paracetamol injection solutions containing propylene glycol as the only cosolvent
12/09/2004	US20040247625 Pharmaceutical composition comprising a water/oil/water double microemulsion incorporated in a solid support
12/09/2004	US20040247624 Methods of making pharmaceutical formulations for the delivery of drugs having low aqueous solubility
12/09/2004	US20040247623 Method and article for treatment of sensory neuron related disorders through transdermal application of botulinum toxin
12/09/2004	US20040247611 Immunoassay for identifying pathogen-ligand interactions under shear conditions; vaccines containing an anti-adhesive monoclonal antibody, an adhesive peptide, or a pathogen adhesin
12/09/2004	US20040247580 Cultivating a lactic acid bacteria in an aqueous protein solution (e.g., skim milk or soybean protein) containing a proteolytic enzyme; concentrating the solution to coat the culture with the protein; adding a polysaccharide such as xanthan gum, cellulose, or levan; homogenizing; and lyophilizing
12/09/2004	US20040247569 Reduction in bacterial colonization by administering bacteriophage compositions
12/09/2004	US20040247561 Polylactic, glycolic, or mendelic acid or copolymers in which the terminal hydroxy groups have been esterified or etherified and the terminal carboxy group optionally neutralized with Li, Na or K; capable of forming micelles in an aqueous solution with a pH of 4 or more
12/09/2004	US20040247560 Improved palatability, especially masking the bitter taste of quinolone antibiotics; particle size of less than 50 mu m. delays the formation of a sediment and means that the sediment is very easy to reagitate.
12/09/2004	US20040247541 Hydrophilic ingredient such as biotin, carnitine and derivatives thereof, creatine and derivatives thereof, folic acid, pyridoxine, niacinamide, polyphenols, ascorbic acid, Hamamelis, Aloe, or panthenol containing as a photostabilizer a di(C 6-24 branched or unbranched alkyl) 2,6-naphthalenedicarboxylate
12/09/2004	US20040247532 NaCl, KCl, NaHCO3, monobasic or dibasic potassium phosphate saliva substitute; triclosan, chlorhexidine or benzalkonium and salts, or cetylpyridium chloride antiseptic; NaF, Na2PO3F, or xylitol anticariogenic agent; vitamin E acetate, panthenol, dipotassium glycyrrhizinate, or aloe vera extract
12/09/2004	US20040247530 Pharmaceutical composition comprising salmeterol and budesonide for the treatment of respitory disorders
12/09/2004	US20040247529 Administering a pulmonary surfactant preparation, including a phosphatide and/or a surfactant protein to artificially respirate a patient suffering from a toxic oxygen concentration; side effect reduction
12/09/2004	US20040247528 Such as a vaporizer, a massage unit, heating or cooling units, which are camouflaged in a decorative object or in a clothing item or in a utilitarian object, such as a piece of furniture, all of which are worn or located adjacent a person who can obtain the therapeutic benefits from the items
12/09/2004	US20040245675 Injection molding process for the preparation of an oral delivery device for a pharmaceutically active agent
12/09/2004	US20040245662 Method for preparing submicron particles of antineoplastic agents
12/09/2004	US20040244794 Inhalation device with a pharmaceutical composition
12/09/2004	DE29624506U1 Oral composition for poorly soluble basic drugs and macrolide antibiotics - contains alginate complex matrix and organic acid
12/09/2004	DE102004012273A1 Stabile und geschmacksmaskierte pharmazeutische Dosierungsform unter Verwendung von porösen Apatit-Körnern Stable and taste masked pharmaceutical dosage form using porous apatite grains
12/09/2004	DE10015928B4 Träger für ein Arzneimittel und Verfahren zur Überprüfung der Unversehrtheit dieses Trägers Support for a medicinal product and method for verifying the integrity of this carrier
12/09/2004	CA2820174A1 Low sodium solution for dialysis
12/09/2004	CA2532707A1 Novel topical steroid cream formulations
12/09/2004	CA2527772A1 Tumor-targeted drug delivery systems and uses thereof
12/09/2004	CA2527722A1 Biodegradable poly(beta-amino esters) and uses thereof
12/09/2004	CA2527431A1 Deramciclane-fumarate tablets
12/09/2004	CA2527429A1 Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents
12/09/2004	CA2527301A1 Oligonucleic acid-bearing composite and pharmaceutical composition containing the composite
12/09/2004	CA2527178A1 New long-acting drug combinations for the treatment of respiratory complaints
12/09/2004	CA2527133A1 Method and composition for stable and controlled delivery of (-)-hydroxycitric acid
12/09/2004	CA2525973A1 Combination chemotherapy comprising capecitabine and a liposomal platinum complex
12/09/2004	CA2525952A1 Combination chemotherapy comprising gemcitabine and a liposomal platinum complex
12/09/2004	CA2525865A1 Antimicrobial quaternary ammonium organosilane coatings
12/09/2004	CA2524375A1 Topical composition for the treatment of skin disorders and methods of using the same
12/09/2004	CA2524094A1 Low sodium solution
12/09/2004	CA2495270A1 Transdermal vaccine delivery device having coated microprotrusions
12/08/2004	EP1484332A2 Lipid-based drug delivery system for administration of a drug substance
12/08/2004	EP1484081A1 Systems and methods for treating ischemia
12/08/2004	EP1484080A1 Biodegradable, anionic polymers
12/08/2004	EP1484061A1 Drugs containing riboflavin-type compounds
12/08/2004	EP1484056A1 Sustained release preparations and process for producing the same
12/08/2004	EP1484055A1 Delivery system with increased bioavailability
12/08/2004	EP1484054A1 Drug delivery system for the subconjunctival administration of fine grains
12/08/2004	EP1484053A2 Percutaneously applicable preparation and suppository containing an antidementia medicament
12/08/2004	EP1484033A1 Liquid polymeric compositions for controlled release of bioactive substances
12/08/2004	EP1483978A1 Biological process for the production of a food product comprising heme-iron and food product obtained with said process
12/08/2004	EP1483366A1 Antimicrobial composition
12/08/2004	EP1483313A1 Polymer composite with internally distributed deposition matter
12/08/2004	EP1483231A1 Novel cinnamate salts, method for production and use thereof as medicaments
12/08/2004	EP1482994A1 Absorbent hydrogels
12/08/2004	EP1482980A1 Prostaglandin composition for the treatment of erectile dysfunction
12/08/2004	EP1482974A2 Electroporation methods for introducing bioactive agents into cells
12/08/2004	EP1482967A1 Pharmaceutical and cosmetic compositions comprising plgf-1
12/08/2004	EP1482949A1 Sulfatase inhibiting progestogen-only contraceptive regimens
12/08/2004	EP1482948A1 Continuous sulfatase inhibiting progestogen hormone replacement therapy
12/08/2004	EP1482947A1 Extended cycle estrogen and sulfatase inhibiting progestogen contraceptive regimens
12/08/2004	EP1482946A1 Progesterone oral drug delivery system
12/08/2004	EP1482942A2 Stabilized pharmaceutical compositions of halofuginone and other quinazolinone derivatives
12/08/2004	EP1482938A1 Pharmaceutical composition of a pde4 or a pde3/4 inhibitor and a histamine receptor antagonist
12/08/2004	EP1482936A1 Ophthalmic composition comprising ascomycin
12/08/2004	EP1482931A2 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
12/08/2004	EP1482915A1 Therapeutic system for the controlled release of active ingredients
12/08/2004	EP1482914A2 Implantable drug delivery system
12/08/2004	EP1482913A1 A system for the controlled release of active ingredients
12/08/2004	EP1482912A2 Naltrexone hydrochloride compositions
12/08/2004	EP1482911A1 Dispersed solid-containing complex carbohydrate
12/08/2004	EP1482910A1 Modified release oral pharmaceutical composition
12/08/2004	EP1482811A1 Probiotic delivery system
12/08/2004	EP1482796A1 Stable compositions comprising tezacitabine
12/08/2004	EP1482795A1 New immunoeffector compounds
12/08/2004	EP1482789A2 Palatable oral suspension and method
12/08/2004	EP1444247A4 Novel tibolone formulations
12/08/2004	EP1432312A4 Use of non-toxic crosslinking reagents to improve fatigue resistance and reduce mechanical degradation of intervertebral disc and other collagenous tissues
12/08/2004	EP1339403B1 Repinotan kit
12/08/2004	EP1240355A4 Removal of dye-labeled dideoxy terminators from dna sequencing reactions
12/08/2004	EP1221947B1 Soft gel capsule resistant to gastric juices
12/08/2004	EP1220693B1 Formulations for delivery of osteogenic proteins
12/08/2004	EP1171107B1 Use of a pharmaceutical composition in the manufacture of a medicament for the treatment of pathological conditions of the eye caused by bacteria, viruses, fungi, yeasts and protozoa
12/08/2004	EP1168934A4 Hydrogel-forming system with hydrophobic and hydrophilic components
12/08/2004	EP1115433B1 Functionalized derivatives of hyaluronic acid, formation of hydrogels and in situ using same
12/08/2004	EP1027062B1 Germicidal compositions for the treatment of animal infectious diseases of the hoof, comprising a copper salt, a quaternary ammonium compound and a peroxide
12/08/2004	EP0991402B1 Process for preparing a poly(vinyl alcohol) cryogel
12/08/2004	EP0984925B1 Compounds, preparation and use for transferring nucleic acids into cells
12/08/2004	EP0975329B1 Lipid complexes of highly insoluble platinum complexes
12/08/2004	EP0904086B1 Transdermal systems containing two active principles in separate compartments, their method of preparation and application as medicine
12/08/2004	EP0904067B1 Transdermally administered dextromethorphan as antitussive agent
12/08/2004	EP0863729B1 Implantable controlled release device to deliver drugs directly to an internal portion of the body
12/08/2004	CN2661188Y Acesodyne plaster
12/08/2004	CN2661187Y Plaster administered device for lumbago
12/08/2004	CN1553918A Novel dammarane sapogenins, their use as anti-cancer agents, and a process for producing same
12/08/2004	CN1553816A Polysaccharide-containing compositions and use thereof
12/08/2004	CN1553815A Pharmaceutical formulation for the intramuscular administration of fulvestrant
12/08/2004	CN1553811A Human tissue urokinase type plasminogen activator formulation
12/08/2004	CN1553810A Use of HCG and LH in controlled ovarian hyperstimulation
12/08/2004	CN1553808A Use of HCG in controlled ovarian hyperstimulation

1 ... 1900 1901 1902 1903 1904 1905 1906 1907 1908 1909 1910 1911 1912 1913 1914 1915 1916 1917 1918 1919 1920 ... 2991